GLP-3 (RT) is a synthetic peptide, identified by the testing laboratory as “GLP RT”, that belongs to the class of triple incretin receptor agonist research peptides. Compounds in this class are designed to act at three related class B G-protein-coupled receptors: the GLP-1 receptor, the GIP receptor and the glucagon receptor.
Research interest centres on multi-receptor pharmacology: how activity at the glucagon receptor adds to combined GLP-1 and GIP receptor agonism. Laboratory studies examine relative receptor potency, cAMP signalling in receptor-expressing cell lines, and downstream metabolic signalling in cultured hepatocyte and pancreatic beta-cell models.
Each vial contains 10, 20, 30 or 40 mg of GLP-3 (RT) (select a size above) as a lyophilized powder. Reconstitute with bacteriostatic water (sold separately) before laboratory use. The COA & Testing tab lists the tested batch, with links to verify it on COA Coalition and with the laboratory.












